Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial

Clinical Trial ID NCT01847235

Rank	Title	Journal	Year	PubWeight™‹?›
1	Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.	N Engl J Med	2005	74.55
2	Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.	J Natl Cancer Inst	1998	5.30
3	Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.	J Clin Oncol	1999	3.30
4	Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study.	J Clin Oncol	2010	2.46
5	Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule: the "rescue" approach.	Cancer	2008	1.57
6	Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors.	Int J Cancer	2005	1.48
7	Oligodendroglioma.	Crit Rev Oncol Hematol	2008	1.01
8	Treatment Patterns, Survival, and Healthcare Costs of Patients with Malignant Gliomas in a Large US Commercially Insured Population.	Am Health Drug Benefits	2014	0.92
9	A phase II trial of primary temozolomide in patients with grade III oligodendroglial brain tumors.	Neuro Oncol	2010	0.85